Brief: Bajaj Healthcare Gets Approval From DCGI To Manufacture API And Drug Formulation Of Pimavanserin
30/01/2025 08:32
Jan 30 (Reuters) - Bajaj Healthcare Ltd BAJH.NS :
* GETS APPROVAL FROM DCGI TO MANUFACTURE API AND DRUG
FORMULATION
OF PIMAVANSERIN
Source text: ID:
Further company coverage: BAJH.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Bajaj Healthcare
See all newsIndia's Bajaj Healthcare falls on agreement to sell Gujarat undertaking for $1.5 million
Brief: Bajaj Healthcare June-Quarter Profit 137 Million Rupees
Brief: Bajaj Healthcare's Board Approves Sale Of Operational Business Unit At Tarapur
Brief: Bajaj Healthcare Ltd Posts March-Quarter Loss 228.5 Million Rupees
Brief: Bajaj Healthcare Posts Dec-Quarter Profit Of 156.7 Million Rupees